Immune-related adverse events predict the therapeutic efficacy of anti–PD-1 antibodies in cancer patients

1. Rogado, J.
2. Sánchez-Torres, J.M.
3. Romero-Laorden, N.
4. Ballesteros, A.I.
5. Pacheco-Barcia, V.
6. Ramos-Leví, A.
7. Arranz, R.
8. Lorenzo, A.
9. Gullón, P.
10. Donnay, O.
11. Adrados, M.
12. Costas, P.
13. Aspa, J.
14. Alfranca, A.
15. Mondéjar, R.
16. Colomer, R.